The influence of C-reactive protein-triglyceride-glucose index (CTI) on the prognosis of heart failure patients with different ejection fractions - Scorecard - MDSpire
Advertisement
The influence of C-reactive protein-triglyceride-glucose index (CTI) on the prognosis of heart failure patients with different ejection fractions
Clinical Scorecard: Impact of the C-reactive Protein-Triglyceride-Glucose Index (CTI) on Prognostic Outcomes in Heart Failure Patients with Varying Ejection Fractions
At a Glance
Category
Detail
Condition
Key Mechanisms
Integration of inflammation and insulin resistance via CTI, specifically its role in predicting outcomes in CHF.
Target Population
Care Setting
Key Highlights
CTI is an independent prognostic marker for all-cause mortality in CHF patients, highlighting its clinical relevance.
Guideline-Based Recommendations
Diagnosis
Diagnosis of CHF based on 2021 ESC Guidelines, specifically referencing the classification of heart failure.
Management
Monitoring & Follow-up
Risks
Patient & Prescribing Data
CTI may serve as a useful biomarker for risk stratification, potentially guiding therapeutic decisions.
Clinical Best Practices
Utilize CTI for assessing prognosis in CHF patients, supported by recent studies demonstrating its predictive value.
